BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  What You Need to Know About Indalo Therapeutics

  Indalo Therapeutics is based in St. Louis and was formed in October 2016 from the merger of Antegrin Therapeutics and Cascadia Therapeutics.

  December 7, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  What You Need to Know About Jecure Therapeutics

  Jecure Therapeutics, based in San Diego, stated operations in mid-2016 with a focus on NASH and liver fibrosis.

  December 7, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Sage Therapeutics Erupts as Depression Drug Wows in Mid-Stage Study

  Shares of Sage have shot up more than 75 percent this morning as a result of the impressive data.

  December 7, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  San Diego’s Halozyme Lands Potential $680M R&D Deal With Alexion

  Alexion will use Halozyme’s ENHANZE drug-delivery technology to develop subcutaneous formulations for that company’s portfolio of products.

  December 7, 2017

   · 

  2 min read

   · 

  Alex Keown
• Business

  Sarah Cannon Joins Early Breast Cancer Detection Study

  Sarah Cannon, the Cancer Institute of HCA Healthcare, announced today that several of its affiliated programs will participate in a new study, called STRIVE, which focuses on developing a test for early breast cancer detection.

  December 7, 2017

   · 

  3 min read
• Business

  BGI & Sanguine Join Forces to Increase Speed and Efficiency of Precision Clinical Trial Recruitment

  The combined offering will allow drug developers to significantly increase the homogeneity of their trial cohorts, reducing risk and cost and increasing the likelihood of success.

  December 7, 2017

   · 

  2 min read
• Policy

  Veeva CRM and Veeva OpenData Help the Life Sciences Industry Meet Compliance Requirements in Ohio

  Ohio law requires that all healthcare organizations (HCOs) have Terminal Distributor of Dangerous Drugs (TDDD) licenses to distribute the drugs that healthcare professionals (HCPs) are prescribing.

  December 7, 2017

   · 

  3 min read
• Business

  Curadev Announces Research Partnership With University of Texas Southwestern Medical Center, Dallas, TX, USA

  Curadev Pharma, India and UT Southwestern Medical Center in Dallas, USA announce a translational research partnership to identify small molecule drugs for the treatment of specific cancers.

  December 7, 2017

   · 

  1 min read
• Biotech Beach

  CMS Issues Proposed National Coverage Determination of NGS IVDs Including Thermo Fisher Scientific’s Oncomine Dx Target Test

  Once implemented, the NCD would provide Medicare beneficiaries with reimbursable testing using Thermo Fisher Scientific’s multi-biomarker NSCLC diagnostic.

  December 7, 2017

   · 

  3 min read
• Business

  Aerogen Pharma and Lyomark Pharma Partner to Develop Inhaled Surfactant, Begin a Phase II Clinical Trial

  Aerogen Pharma and Lyomark Pharma, an established provider of high-quality medicines for the hospital market, are joining forces to develop a clinically superior treatment for RDS).

  December 7, 2017

   · 

  3 min read